An Asian monogenic diabetes registry: prevalence, long-term renal trajectory and development of a diagnostic algorithm for selection of candidates for genetic testing
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Introduction: Through the National Healthcare Group–Khoo Teck Puat Hospital Monogenic Diabetes Registry, we aimed to determine the prevalence and spectrum of maturity-onset diabetes of the young (MODY), describe the long-term renal trajectory of major MODY subtypes, and develop a diagnostic algorithm based on a combination of clinical parameters and biomarkers to refine selection of candidates for genetic testing. Methods: A total of 373 study participants attending secondary care diabetes centres in Singapore were referred for genetic testing. Key inclusion criteria for genetic testing included onset age ≤35 years, body mass index <32.5 kg/m 2 and absence of glutamic acid decarboxylase autoantibody. Results: Analysis of 16 genes and one mitochondrial variant led to a molecular diagnosis in 49 participants, with pathogenic variants present mostly in HNF1A (29%), HNF4A (23%) and GCK (15%). Long-term renal trajectory data observed between these major MODY subtypes were not significantly different, but some key observations were typical for each subgroup. For instance, patients with HNF4A -MODY were predisposed to the risk of microvascular complications (i.e., diabetic kidney disease), while patients with GCK -MODY had mild and non-progressive hyperglycaemia. A structured diagnostic algorithm, including readily available biomarkers such as high-sensitive C-reactive protein (hs-CRP) and high-density lipoprotein-cholesterol (HDL-c), provided 71% diagnostic accuracy, achieving a negative predictive value of 0.94 and a sensitivity of 0.68. Conclusion: The prevalence of MODY (13%) is non-trivial among young-onset diabetes referred for genetic testing based on clinical classifiers suggestive of MODY. Current clinical assessment tools may include hs-CRP and HDL-c to refine selection of candidates for genetic testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Early-onset T2DM is also associated with a more aggressive disease phenotype than later-onset T2DM, characterized by a faster β-cell decline (4), higher glycated hemoglobin (HbA1C), higher body mass index (BMI), a more adverse cardiometabolic risk factor profile (5), earlier insulin dependence (6) and a greater risk of both microvascular and macrovascular complications (4).”
From Living with early-onset type 2 diabetes in young adulthood: a narrative review of lived experience and implications for developmentally appropriate care (2026) · cites this paper as [5]
In the citing paper
“Population-specific diagnostic algorithms incorporating clinical and biochemical features have been developed to better identify candidates for genetic screening among Asian patients with early-onset T2DM”
From Living with early-onset type 2 diabetes in young adulthood: a narrative review of lived experience and implications for developmentally appropriate care (2026) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
The REDCap consortium: building an international community of software platform partners
Harris, P. A., Taylor, R., Minor, B. L., Elliott, V., Fernandez, M., O'Neal, L., McLeod, L., Delacqua, G., Delacqua, F., Kirby, J., et al. (2019) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2019.103208 · Cited by 24,013
Palmer, J. P., Fleming, G. A., Greenbaum, C. J., Herold, K. C., Jansa, L. D., Kolb, H., Lachin, J. M., Polonsky, K. S., Pozzilli, P., Skyler, J. S., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.1.250 · Cited by 491
Nauck, M. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12591 · Cited by 429
Treatment options for MODY patients: a systematic review of literature
Delvecchio, M., Pastore, C., & Giordano, P. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00864-4 · Cited by 172
The Role of Glucagon in the Pathophysiology and Treatment of Type 2 Diabetes
Hædersdal, S., Lund, A., Knop, F. K., & Vilsbøll, T. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.12.003 · Cited by 162
Riddle, M. C., Philipson, L. H., Rich, S. S., Carlsson, A., Franks, P. W., Greeley, S. A. W., Nolan, J. J., Pearson, E. R., Zeitler, P. S., & Hattersley, A. T. (2020) · Diabetes Care · doi:10.2337/dci20-0065 · Cited by 117
Carlsson, A., Shepherd, M., Ellard, S., Weedon, M., Lernmark, Å., Forsander, G., Colclough, K., Brahimi, Q., Valtonen-Andre, C., Ivarsson, S. A., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0747 · Cited by 111
High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes
McDonald, T. J., Shields, B. M., Lawry, J., Owen, K. R., Gloyn, A. L., Ellard, S., & Hattersley, A. T. (2011) · Diabetes Care · doi:10.2337/dc11-0323 · Cited by 105
Research works printed but not linked: 37
- Tattersall, 1974, Mild familial diabetes with dominant inheritance, Q J Med, 43, 339
- Bosselaar, 2002, High sensitivity to sulphonylurea treatment in 2 patients with maturity-onset diabetes of the young type 3, Ned Tijdschr Geneeskd, 146, 726
- Shepherd, 2018, A UK nationwide prospective study of treatment change in MODY: Genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin, Diabetologia, 61, 2520, 10.1007/s00125-018-4728-6 · DOI · Paper page
- Broome, 2020, Novel use of GLP-1 receptor agonist therapy in HNF4A-MODY, Diabetes Care, 43, e65, 10.2337/dc20-0012 · DOI
- Bowman, 2018, Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: An international cohort study, Lancet Diabetes Endocrinol, 6, 637, 10.1016/S2213-8587(18)30106-2 · DOI · Paper page
- Iafusco, 2011, No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes, Diabetologia, 54, 2736, 10.1007/s00125-011-2273-7 · DOI
- Steele, 2013, Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: Observation case control studies, PLoS One, 148, e65326, 10.1371/journal.pone.0065326 · DOI · Paper page
- Steele, 2014, Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia, JAMA, 311, 279, 10.1001/jama.2013.283980 · DOI · Paper page
- Timsit, 2021, Pregnancy in women with monogenic diabetes due to pathogenic variants of the glucokinase gene: Lessons and challenges, Front Endocrinol, 12, 802423, 10.3389/fendo.2021.802423 · DOI
- Shields, 2008, Mutations in the glucokinase gene of the fetus result in reduced placental weight, Diabetes Care, 31, 753, 10.2337/dc07-1750 · doi:10.2337/dc07-1750
- Dubois-Laforgue, 2017, Diabetes, associated clinical spectrum, long-term prognosis, and genotype/phenotype correlations in 201 adult patients with hepatocyte nuclear factor 1B (HNF1B) molecular defects, Diabetes Care, 40, 1436, 10.2337/dc16-2462 · DOI · Paper page
- Johansson, 2011, Diabetes and pancreatic exocrine dysfunction due to mutations in the carboxyl ester lipase gene-maturity onset diabetes of the young (CEL-MODY): A protein misfolding disease, J Biol Chem, 286, 34593, 10.1074/jbc.M111.222679 · DOI
- Mohan, 2019, Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South India, BMC Med Genet, 19, 22, 10.1186/s12881-018-0528-6 · DOI
- Chapla, 2015, Maturity onset diabetes of the young in India – A distinctive mutation pattern identified through targeted next-generation sequencing, Clin Endocrinol, 82, 533, 10.1111/cen.12541 · DOI
- Shields, 2012, The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes, Diabetologia, 55, 1265, 10.1007/s00125-011-2418-8 · DOI · Paper page
- Misra, 2016, South Asian individuals with diabetes who are referred for MODY testing in the UK have a lower mutation pick-up rate than white European people, Diabetologia, 59, 2262, 10.1007/s00125-016-4056-7 · DOI
- Chauhan, 2012, TG/HDL ratio: A marker for insulin resistance and atherosclerosis in prediabetics or not?, J Family Med Prim Care, 10, 3700, 10.4103/jfmpc.jfmpc_165_21 · DOI
- Epstein, 2013, Use of the estimated glucose disposal rate as a measure of insulin resistance in an urban multiethnic population with type 1 diabetes, Diabetes Care, 36, 2280, 10.2337/dc12-1693 · DOI · Paper page
- Whelton, 2018, 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines, J Am Coll Cardiol, 71, e127, 10.1016/j.jacc.2017.11.006 · DOI · Paper page
- Ang, 2020, Clinical experience from a regional monogenic diabetes referral centre in Singapore, Diabetes Res Clin Pract, 168, 108390, 10.1016/j.diabres.2020.108390 · DOI
- Ang, 2016, A preliminary study to evaluate the strategy of combining clinical criteria and next generation sequencing (NGS) for the identification of monogenic diabetes among multi-ethnic Asians, Diabetes Res Clin Pract, 119, 13, 10.1016/j.diabres.2016.06.008 · DOI
- Tan, 2022, MODY5 Hepatocyte nuclear factor 1B (HNF1B)-associated nephropathy: Experience from a regional monogenic diabetes referral centre in Singapore, J Investig Med High Impact Case Rep, 10, 1
- Vigouroux, 2018, Lipodystrophic syndromes due to LMNA muations: Recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives, Nucleus, 9, 235, 10.1080/19491034.2018.1456217 · DOI
- Colclough, 2022, Syndromic monogenic diabetes genes should be tested in patients with a clinical suspicion of maturity-onset diabetes of the young, Diabetes, 71, 530, 10.2337/db21-0517 · DOI
- Owen, 2010, Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations, Diabetes Care, 33, 1919, 10.2337/dc10-0288 · DOI · Paper page
- McDonald, 2012, Lipoprotein composition in HNF1A-MODY: Differentiating between HNF1A-MODY and type 2 diabetes, Clin Chim Acta, 413, 927, 10.1016/j.cca.2012.02.005 · DOI
- Fendler, 2011, HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults, Clin Endocrinol, 75, 321, 10.1111/j.1365-2265.2011.04052.x · doi:10.1111/j.1365-2265.2011.04052.x
- Tfayli, 2009, Phenotypic type 2 diabetes in obese youth: Insulin sensitivity and secretion in islet cell antibody-negative versus – positive patients, Diabetes, 58, 738, 10.2337/db08-1372 · DOI · Paper page
- Besser, 2011, Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 4-(alpha) maturity-onset diabetes of the young from long-duration type 1 diabetes, Diabetes Care, 34, 286, 10.2337/dc10-1293 · DOI · Paper page
- Agladioglu, 2015, Urinary C-peptide/creatinine ratio can distinguish maturity-onset diabetes of the young from type 1 diabetes in children and adolescents: A single-center experience, Hormone Res Paediatr, 84, 54, 10.1159/000375410 · DOI
- Besser, 2013, Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes, Pediatr Diabetes, 14, 181
- Nauck, 2009, Incretin-based therapies: Viewpoints on the way to consensus, Diabetes Care, 32, S223, 10.2337/dc09-S315 · DOI · Paper page
- Hu, 2021, Association between plasma uric acid and insulin resistance in type 2 diabetes: A Mendelian randomization analysis, Diabetes Res Clin Pract, 171, 108542, 10.1016/j.diabres.2020.108542 · DOI
- Xiong, 2019, Effects of uric acid on diabetes mellitus and its chronic complications, Int J Endocrinol, 2019, 9691345, 10.1155/2019/9691345 · DOI
- DeFronzo, 1979, Glucose clamp technique: A method for quantifying insulin secretion and resistance, Am J Physiol, 237, E214
- Bergman, 1985, Assessment of insulin sensitivity in vivo, Endocr Rev, 6, 45, 10.1210/edrv-6-1-45 · DOI · Paper page
- McDonald, 2011, Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes, Diabetic Med, 28, 1028, 10.1111/j.1464-5491.2011.03287.x · DOI · Paper page
Cited by
Goh, J. S. R., Sim, L. X., Seetho, I. W., Kao, S. L., Chin, R. T., Khoo, C. M., Lim, A. Y. L., & Eng, P. C. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1903159
Metadata
- Authors
- Tan, C. S. H., Kee, K. X., Zheng, H., Chan, L. W. T., Song, Y., Kon, W. Y. C., Chee, Y. J., Lian, J. X., Vasanwala, R. F., Yap, F. K. P., Loh, W. J., Subramaniam, T., Sum, C. F., & Lim, S. C.
- Affiliations
- Clinical Research Unit, Khoo Teck Puat Hospital, Singapore
- Department of Endocrinology, Tan Tock Seng Hospital, Singapore
- Department of Endocrinology, KKH Women’s and Children’s Hospital, Singapore
- Department of Endocrinology, Changi General Hospital, Singapore
- Diabetes Centre, Admiralty Medical Centre, Singapore
- Venue
- Singapore Medical Journal
- Published
- 2025-02-18
- ISSN
- 0037-5675
- 2737-5935
- Cited by
- 4
- References
- 9
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An Asian monogenic diabetes registry: prevalence, long-term renal trajectory and development of a diagnostic algorithm for selection of candidates for genetic testing. https://app.cochat.ai/papers/10.4103/singaporemedj.smj-2024-012
- The paper
- Tan, C. S. H., Kee, K. X., Zheng, H., Chan, L. W. T., Song, Y., Kon, W. Y. C., Chee, Y. J., Lian, J. X., Vasanwala, R. F., Yap, F. K. P., Loh, W. J., Subramaniam, T., Sum, C. F., & Lim, S. C. (2025). An Asian monogenic diabetes registry: prevalence, long-term renal trajectory and development of a diagnostic algorithm for selection of candidates for genetic testing. Singapore Medical Journal. https://doi.org/10.4103/singaporemedj.smj-2024-012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.